{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:05:54Z","timestamp":1792202754239,"version":"4.4.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.mayocp.2017.01.020","type":"journal-article","created":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T15:45:40Z","timestamp":1493135140000},"page":"734-743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Incidence and Mortality of Physician-Diagnosed Primary Sj\u00f6gren Syndrome"],"prefix":"10.1016","volume":"92","author":[{"given":"Gabriel","family":"Maciel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia S.","family":"Crowson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divi","family":"Cornec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mayocp.2017.01.020_bib1","doi-asserted-by":"crossref","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sjogren syndrome","volume":"2","author":"Brito-Zeron","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.mayocp.2017.01.020_bib2","doi-asserted-by":"crossref","unstructured":"Cornec D, Devauchelle-Pensec V, Mariette X, et\u00a0al. Severe health-related quality-of-life impairment in active primary Sjogren's syndrome is driven by patient-reported outcomes: data from a large therapeutic trial [published online July 7, 2016]. Arthritis Care Res (Hoboken). http:\/\/dx.doi.org\/10.1002\/acr.22974.","DOI":"10.1002\/acr.22974"},{"issue":"3","key":"10.1016\/j.mayocp.2017.01.020_bib3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12016-014-8431-1","article-title":"The differential diagnosis of dry eyes, dry mouth, and parotidomegaly: a comprehensive review","volume":"49","author":"Cornec","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7","key":"10.1016\/j.mayocp.2017.01.020_bib4","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/rheumatology\/kew023","article-title":"Previous diagnosis of Sjogren's Syndrome as rheumatoid arthritis or systemic lupus erythematosus","volume":"55","author":"Rasmussen","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.mayocp.2017.01.020_bib5","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/acr.21610","article-title":"Primary Sjogren's syndrome as a systemic disease: a study of participants enrolled in an international Sjogren's syndrome registry","volume":"64","author":"Malladi","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"10.1016\/j.mayocp.2017.01.020_bib6","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/rheumatology\/kev200","article-title":"Characterization of systemic disease in primary Sjogren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements","volume":"54","author":"Ramos-Casals","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.mayocp.2017.01.020_bib7","doi-asserted-by":"crossref","first-page":"e000179","DOI":"10.1136\/rmdopen-2015-000179","article-title":"Epidemiology of neurological manifestations in Sjogren's syndrome: data from the French ASSESS Cohort","volume":"2","author":"Carvajal Alegria","year":"2016","journal-title":"RMD Open"},{"issue":"9","key":"10.1016\/j.mayocp.2017.01.020_bib8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nrrheum.2013.110","article-title":"Advances in understanding the pathogenesis of primary Sjogren's syndrome","volume":"9","author":"Nocturne","year":"2013","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"10.1016\/j.mayocp.2017.01.020_bib9","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/art.39127","article-title":"Familial risk of Sjogren's syndrome and co-aggregation of autoimmune diseases in affected families: a nationwide population study","volume":"67","author":"Kuo","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.mayocp.2017.01.020_bib10","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ng.2792","article-title":"Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome","volume":"45","author":"Lessard","year":"2013","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.mayocp.2017.01.020_bib11","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/art.39560","article-title":"X\u00a0chromosome dose and sex bias in autoimmune diseases: increased prevalence of 47,XXX in systemic lupus erythematosus and Sjogren's syndrome","volume":"68","author":"Liu","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.mayocp.2017.01.020_bib12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/rheumatology\/keu400","article-title":"Clinical characteristics of RA patients with secondary SS and association with joint damage","volume":"54","author":"Brown","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.mayocp.2017.01.020_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaut.2016.06.008","article-title":"Analysis of the cell populations composing the mononuclear cell infiltrates in the labial minor salivary glands from patients with rheumatoid arthritis and sicca syndrome","volume":"73","author":"Fragoulis","year":"2016","journal-title":"J\u00a0Autoimmun"},{"issue":"4","key":"10.1016\/j.mayocp.2017.01.020_bib14","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/art.39518","article-title":"Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sjogren's syndrome","volume":"68","author":"Nocturne","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.mayocp.2017.01.020_bib15","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2017.01.020_bib16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/acr.21591","article-title":"American College of Rheumatology classification criteria for Sjogren's syndrome: a data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance cohort","volume":"64","author":"Shiboski","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.mayocp.2017.01.020_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2013-203845","article-title":"Comparison of the American-European Consensus Group Sjogren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort","volume":"73","author":"Rasmussen","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2017.01.020_bib18","doi-asserted-by":"crossref","first-page":"R74","DOI":"10.1186\/ar4514","article-title":"Level of agreement between 2002 American-European Consensus Group and 2012 American College of Rheumatology classification criteria for Sjogren's syndrome and reasons for discrepancies","volume":"16","author":"Cornec","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.mayocp.2017.01.020_bib19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2012-202565","article-title":"Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issue","volume":"72","author":"Vitali","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2017.01.020_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2017.01.020_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.mayocp.2017.01.020_bib22","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of primary Sjogren's syndrome: a systematic review and meta-analysis","volume":"74","author":"Qin","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2017.01.020_bib23","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1136\/annrheumdis-2014-206860","article-title":"Is primary Sjogren's syndrome an orphan disease? a critical appraisal of prevalence studies in Europe","volume":"74","author":"Cornec","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.mayocp.2017.01.020_bib24","doi-asserted-by":"crossref","unstructured":"Maciel G, Crowson CS, Matteson EL, Cornec D. Prevalence of primary Sjogren's syndrome in a population-based cohort in the United States [published online December 20, 2016]. Arthritis Care Res (Hoboken). http:\/\/dx.doi.org\/10.1002\/acr.23173.","DOI":"10.1002\/acr.23173"},{"issue":"2","key":"10.1016\/j.mayocp.2017.01.020_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/03009742.2014.931457","article-title":"Incident cases of primary Sjogren's syndrome during a 5-year period in Stockholm County: a descriptive study of the patients and their characteristics","volume":"44","author":"Kvarnstrom","year":"2015","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"10.1016\/j.mayocp.2017.01.020_bib26","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00296-016-3474-7","article-title":"Estimating the incidence of connective tissue diseases and vasculitides in a defined population in Northern Savo area in 2010","volume":"36","author":"Elfving","year":"2016","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.mayocp.2017.01.020_bib27","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0025-6196(11)62408-7","article-title":"Incidence of physician-diagnosed primary Sjogren syndrome in residents of Olmsted County, Minnesota","volume":"76","author":"Pillemer","year":"2001","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"10.1016\/j.mayocp.2017.01.020_bib28","doi-asserted-by":"crossref","first-page":"e003569","DOI":"10.1136\/bmjopen-2013-003569","article-title":"Primary Sjogren's syndrome 1976-2005 and associated interstitial lung disease: a population-based study of incidence and mortality","volume":"3","author":"Nannini","year":"2013","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.mayocp.2017.01.020_bib29","first-page":"450","article-title":"Rate, risk factors and causes of mortality in patients with Sjogren's syndrome: a systematic review and meta-analysis of cohort studies","volume":"55","author":"Singh","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.mayocp.2017.01.020_bib30","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/aje\/kwq482","article-title":"Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project","volume":"173","author":"St Sauver","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"12","key":"10.1016\/j.mayocp.2017.01.020_bib31","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.mayocp.2012.08.012","article-title":"History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population","volume":"87","author":"Rocca","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.mayocp.2017.01.020_bib32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mayocp.2011.11.009","article-title":"Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project","volume":"87","author":"St Sauver","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.mayocp.2017.01.020_bib33","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2017.01.020_bib34","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/annrheumdis-2013-204615","article-title":"Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)","volume":"74","author":"Seror","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2017.01.020_bib35","doi-asserted-by":"crossref","first-page":"e000022","DOI":"10.1136\/rmdopen-2014-000022","article-title":"EULAR Sjogren's syndrome disease activity index (ESSDAI): a user guide","volume":"1","author":"Seror","year":"2015","journal-title":"RMD Open"},{"issue":"2","key":"10.1016\/j.mayocp.2017.01.020_bib36","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/annrheumdis-2014-206008","article-title":"Defining disease activity states and clinically meaningful improvement in primary Sjogren's syndrome with EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)","volume":"75","author":"Seror","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2017.01.020_bib37","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/art.20146","article-title":"Inefficacy of infliximab in primary Sjogren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjogren's Syndrome (TRIPSS)","volume":"50","author":"Mariette","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.mayocp.2017.01.020_bib38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/M13-1085","article-title":"Treatment of primary Sjogren syndrome with rituximab: a randomized trial","volume":"160","author":"Devauchelle-Pensec","year":"2014","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.mayocp.2017.01.020_bib39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.2014.7682","article-title":"Effects of hydroxychloroquine on symptomatic improvement in primary Sjogren syndrome: the JOQUER randomized clinical trial","volume":"312","author":"Gottenberg","year":"2014","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.mayocp.2017.01.020_bib40","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/rheumatology\/kev114","article-title":"Development of the Sjogren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy","volume":"54","author":"Cornec","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.mayocp.2017.01.020_bib41","doi-asserted-by":"crossref","first-page":"e0133907","DOI":"10.1371\/journal.pone.0133907","article-title":"Which and how many patients should be included in randomised controlled trials to demonstrate the efficacy of biologics in primary Sjogren's syndrome?","volume":"10","author":"Devauchelle-Pensec","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.mayocp.2017.01.020_bib42","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nrrheum.2016.100","article-title":"Treatment of primary Sjogren syndrome","volume":"12","author":"Saraux","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.mayocp.2017.01.020_bib43","doi-asserted-by":"crossref","unstructured":"Carsons SE, Vivino FB, Parke A, et\u00a0al. Treatment guidelines for rheumatologic manifestations of Sjogren's: use of biologics, management of fatigue and inflammatory musculoskeletal pain [published online July 7, 2016]. Arthritis Care Res (Hoboken). http:\/\/dx.doi.org\/10.1002\/acr.22968.","DOI":"10.1002\/acr.22968"},{"issue":"3","key":"10.1016\/j.mayocp.2017.01.020_bib44","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.rdc.2016.03.010","article-title":"New treatment guidelines for Sjogren's disease","volume":"42","author":"Vivino","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"issue":"6","key":"10.1016\/j.mayocp.2017.01.020_bib45","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.berh.2016.02.009","article-title":"New biological therapies in Sjogren's syndrome","volume":"29","author":"Nocturne","year":"2015","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.mayocp.2017.01.020_bib46","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/ard.2003.014027","article-title":"Incidence of primary Sjogren's syndrome in Slovenia","volume":"63","author":"Plesivcnik Novljan","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2017.01.020_bib47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/rheumatology\/kei107","article-title":"Epidemiology of primary Sjogren's syndrome in north-west Greece, 1982-2003","volume":"45","author":"Alamanos","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.mayocp.2017.01.020_bib48","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3899\/jrheum.100883","article-title":"Incidence and mortality of treated primary Sjogren's syndrome in Taiwan: a population-based study","volume":"38","author":"Weng","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.mayocp.2017.01.020_bib49","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.semarthrit.2013.06.001","article-title":"Sex- and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: a Taiwan population-based study","volume":"43","author":"See","year":"2013","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.mayocp.2017.01.020_bib50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/acr.21820","article-title":"Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan","volume":"65","author":"Yu","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.mayocp.2017.01.020_bib51","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/acr.22115","article-title":"Epidemiology of primary Sjogren's syndrome in a French multiracial\/multiethnic area","volume":"66","author":"Maldini","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"10.1016\/j.mayocp.2017.01.020_bib52","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.autrev.2015.07.002","article-title":"Anti-SSA\/SSB-negative Sjogren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution","volume":"14","author":"Quartuccio","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.mayocp.2017.01.020_bib53","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/acr.21956","article-title":"Pain severity and neuropathic pain symptoms in primary Sjogren's syndrome: a comparison study of seropositive and seronegative Sjogren's syndrome patients","volume":"65","author":"Segal","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"10.1016\/j.mayocp.2017.01.020_bib54","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1136\/annrheumdis-2013-204634","article-title":"The prognostic value of routinely performed minor salivary gland assessments in primary Sjogren's syndrome","volume":"73","author":"Risselada","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2017.01.020_bib55","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.semarthrit.2014.05.015","article-title":"Is minor salivary gland biopsy more than a diagnostic tool in primary Sjogren's syndrome? association between clinical, histopathological, and molecular features: a retrospective study","volume":"44","author":"Carubbi","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.mayocp.2017.01.020_bib56","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0961203314554251","article-title":"A\u00a0retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjogren's syndrome","volume":"24","author":"Carubbi","year":"2015","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.mayocp.2017.01.020_bib57","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/annrheumdis-2014-206418","article-title":"Systemic activity and mortality in primary Sjogren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients","volume":"75","author":"Brito-Zeron","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.mayocp.2017.01.020_bib58","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/rheumatology\/kew194","article-title":"Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sjogren syndrome: analysis of 515 patients","volume":"55","author":"Retamozo","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.mayocp.2017.01.020_bib59","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/art.20176","article-title":"Mortality and causes of death in primary Sjogren's syndrome: a prospective cohort study","volume":"50","author":"Theander","year":"2004","journal-title":"Arthritis Rheum"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619617301167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619617301167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T19:26:11Z","timestamp":1719170771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619617301167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0025619617301167"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2017.01.020","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Mortality of Physician-Diagnosed Primary Sj\u00f6gren Syndrome","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2017.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}